Quirion R, Araujo D, Regenold W, Boksa P
Douglas Hospital Research Centre, Faculty of Medicine, McGill University, Verdun, Quebec, Canada.
Neuroscience. 1989;29(2):271-89. doi: 10.1016/0306-4522(89)90057-2.
[3H]Acetylcholine receptor binding characteristics (under muscarinic conditions) have been investigated using membrane binding assays and in vitro receptor autoradiography. In rat, guinea-pig and monkey brain membrane preparations, [3H]acetylcholine binds with high affinity (25-50 nM) to an apparently single class of sites which is differentially distributed across brain regions. The ligand selectivity pattern reveals that the potency of (-)quinuclidinyl benzylate is greater than (greater than) atropine greater than scopolamine greater than oxotremorine greater than carbamylcholine greater than pirenzepine greater than methylcarbamyl-choline = nicotine in competing for [3H]acetylcholine binding sites, indicating that [3H]acetylcholine selectively binds to muscarinic sites under these incubation conditions. Moreover, the low potency of pirenzepine suggests that [3H]acetylcholine does not label a significant proportion of the M1 receptor sub-type but most likely binds to putative M2-like receptor sites. This hypothesis is also supported by the autoradiographic distribution of [3H]acetylcholine binding sites in all species studied here. High densities of [3H]acetylcholine binding sites are seen in various nuclei of the medulla and pons, certain thalamic nuclei, medial septum, laminae III, V and VI of the cortex and just above the pyramidal cell layer of the hippocampus. Such localization is much different from that seen with the non-selective antagonist [3H]quinuclidinyl benzylate and the selective M1 receptor ligand [3H]pirenzepine, although it resembles that of the selective M2 receptor antagonist [3H]AF-DX 116. Thus, [3H]acetylcholine apparently mostly binds with high affinity mainly to non-M1 muscarinic receptor types in mammalian brain tissues. Moreover, the ligand selectivity pattern and in vitro receptor autoradiographic data suggest that at low concentrations (10-20 nM) most of [3H]actylcholine labelled sites are of the M2-like receptor class.
利用膜结合分析法和体外受体放射自显影技术,研究了[³H]乙酰胆碱受体结合特性(在毒蕈碱条件下)。在大鼠、豚鼠和猴的脑膜制备物中,[³H]乙酰胆碱以高亲和力(25 - 50 nM)与一类明显单一的位点结合,这些位点在脑区中的分布存在差异。配体选择性模式显示,在竞争[³H]乙酰胆碱结合位点时,(-)喹核醇基苯甲酸酯的效力大于阿托品大于东莨菪碱大于氧化震颤素大于氨甲酰胆碱大于哌仑西平大于甲基氨甲酰胆碱 = 尼古丁,这表明在这些孵育条件下,[³H]乙酰胆碱选择性地与毒蕈碱位点结合。此外,哌仑西平的低效价表明,[³H]乙酰胆碱并未标记出相当比例的M1受体亚型,而是最有可能与假定的M2样受体位点结合。本文研究的所有物种中[³H]乙酰胆碱结合位点的放射自显影分布也支持了这一假设。在延髓和脑桥的各个核团、某些丘脑核、内侧隔区、皮质的III、V和VI层以及海马锥体细胞层上方可见高密度的[³H]乙酰胆碱结合位点。这种定位与非选择性拮抗剂[³H]喹核醇基苯甲酸酯和选择性M1受体配体[³H]哌仑西平的定位有很大不同,尽管它与选择性M2受体拮抗剂[³H]AF - DX 116的定位相似。因此,[³H]乙酰胆碱在哺乳动物脑组织中显然主要以高亲和力与非M1毒蕈碱受体类型结合。此外,配体选择性模式和体外受体放射自显影数据表明,在低浓度(10 - 20 nM)下,大部分[³H]乙酰胆碱标记的位点属于M2样受体类别。